Beeline Medicines-preview

Beelinemedicines

Beeline Medicines

Private

Stamford, ConnecticutHealthcare & Life Scienceshttps://beelinemedicines.com/

Last Round

Series A

4/16/2026

Total Funding Raised

$600M

Company Overview

Beeline Medicines is a biotechnology company that develops precision therapies for autoimmune and inflammatory diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

precision therapiesautoimmune disease therapyinflammatory disease therapyclinical-stage biotechdrug pipeline developmentdrug in-licensingpharma spin-outlupus therapyasset-centric biotechimmunology therapeuticsTLR7/8 inhibitorsmall molecule drugstargeted therapybiologic therapiespsoriasis therapyTYK2 inhibitoratopic dermatitis therapySLECLE

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Beeline Medicines Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Beeline Medicines Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	4/16/2026
Series A	7/1/2025

View all Funding Rounds

Beeline Medicines Investors

Notable investors and investment history

Investor	Rounds
Bain Capital, LP	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 16, 2026
$300M round raised.
Jul 1, 2025
$300M Series A round raised.

View all signals

Beeline Medicines Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Beeline Medicines Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Beeline Medicines's valuation, stock price, and market status.

Firmographic Details

HeadquartersStamford, Connecticut

Year Founded2025

Last Funding4/16/2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

Login

Use CasesInvestors Employees

CompaniesAll Companies

LegalPrivacy Policy Terms of Use BrokerCheck Form CRS

DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.